Last reviewed · How we verify
NCT04125979: CEVNPIMISELC
Clinical Evaluation of Vagal Nerve Preservation in Minimally Invasive Surgery for Early Lung Cancer
NA trial testing In minimally invasive surgery，Vagus nerve preservation in Lung Cancer Stage I in 120 participants. Status unknown.
30 January 2021
Quick facts
| Lead sponsor | Shanghai Tongji Hospital, Tongji University School of Medicine |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 120 |
| Start date | 1 January 2019 |
| Primary completion | 30 January 2021 |
| Estimated completion | 31 January 2022 |
| Sites | 1 location across China |
Drugs / interventions tested
- In minimally invasive surgery，Vagus nerve preservation
- In minimally invasive surgery，Vagus nerve is not preserved
Conditions studied
- Lung Cancer Stage I — all drugs for Lung Cancer Stage I →
Sponsor
Shanghai Tongji Hospital, Tongji University School of Medicine
Who can join
Adults 18 to 80, any sex, with Lung Cancer Stage I. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Through prospective, randomized and controlled clinical study, patients with early lung cancer who do not need lymph node dissection according to routine diagnosis and treatment were selected. The feasibility and safety of preserving vagal pulmonary branch intact during minimally invasive surgery were compared with traditional minimally invasive surgery, and the feasibility and safety of preserving vagal pulmonary branch intact during minimally invasive surgery were clarified. The effect of preserving pulmonary branches of vagus nerve in minimally invasive surgery of early lung cancer on preventing or reducing pulmonary complications after operation was evaluated by main observation indexes (incidence of pulmonary complications) and secondary evaluation indexes. It will provide a safer, simpler and more effective new technology for patients with early lung cancer undergoing minimally invasive surgery, and provide a basis for the popularization of this new technology.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04125979
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Lung Cancer Stage I
Currently open trials in the same condition.
- NCT06424327 — A Registry for People With Lung Cancer · recruiting
- NCT05832112 — Outside the Cage (OTC) Robotic Lobectomy · NA · active not recruiting
- NCT05281237 — Avecure Flexible Microwave Ablation Probe For Lung Nodules · NA · recruiting
Other Shanghai Tongji Hospital, Tongji University School of Medicine trials
Trials by the same sponsor.
- NCT07384390 — TH-CAR-027 for Grade 4 Gliomas · EARLY_PHASE1 · not yet recruiting
- NCT07043218 — A Clinical Study Exploring Universal CAR-T Cell in Patients With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia · Phase 1 · not yet recruiting
- NCT07064109 — Multi-omics Characterization and Model Construction of Colchicine Anti-inflammatory Therapy Efficacy in ACS Patients · NA · recruiting
- NCT06951425 — An Exploratory Clinical Study of the Efficiency and Safety of TH027 in the Treatment of Relapsed/Refractory Solid Tumors · EARLY_PHASE1 · not yet recruiting
- NCT06987916 — Efficacy and Safety Evaluation of U01(ssCART-19) in B-Cell Lymphoma · Phase 1, PHASE2 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04125979 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Shanghai Tongji Hospital, Tongji University School of Medicine
- Last refreshed: 14 October 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04125979.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing